[High-sensitivity troponin in patients with stable coronary artery disease]
1Isala, afd. Cardiologie, Zwolle.
Insights
Elevated troponin levels in patients without myocardial infarction offer prognostic insights but limited diagnostic value. Their role in identifying high-risk individuals for intervention in general practice requires further investigation.
Area of Science:
- Cardiology
- Biomarkers
- Clinical Diagnostics
Background:
- More sensitive myocardial necrosis markers improve acute myocardial infarction diagnosis.
- Elevated troponin in non-myocardial infarction patients presents diagnostic challenges and prolonged admissions.
- These elevated levels have limited diagnostic but significant prognostic value.
Purpose of the Study:
- To evaluate the utility of high-sensitivity troponin in patients with stable disease or no apparent clinical disease.
- To assess the prognostic value of troponin levels in stable patient populations.
- To determine the practical value for general physicians in daily practice.
Main Methods:
- Studies assessed high-sensitivity troponin in patients with coronary artery disease and those without apparent clinical disease.
- Long-term cardiac mortality was evaluated in relation to troponin levels.
- The cost-effectiveness of interventions in identified high-risk subgroups was considered.
Main Results:
- High-sensitivity troponin consistently showed a strong association with long-term cardiac mortality in stable patients.
- Elevated troponin levels identified individuals at higher risk.
- The diagnostic value in patients without myocardial infarction was limited.
Conclusions:
- Troponin levels are strongly associated with long-term cardiac mortality in stable patients.
- While useful for risk stratification, the clinical utility for guiding interventions in general practice is unclear.
- Further research is needed to determine the prognostic marker role in stable patients and its impact on cost-effective interventions.
Abstract:
With the introduction of more sensitive markers of myocardial necrosis, it was shown that the diagnosis of (acute) myocardial infarction could be improved. However, many patients without myocardial infarction have elevated troponin levels (low sensitivity), resulting in additional diagnostic testing and longer admission times to find the cause of the troponin rise. Elevated troponin levels in these patients were found to have limited diagnostic but strong prognostic value. This led to studies assessing the value of high-sensitivity troponin in patients with stable disease, e.g. coronary artery disease, or even in patients without apparent (clinical) disease. These studies consistently showed a strong association with long-term (cardiac) mortality. What is the value for the general physician in daily practice? Although troponin levels may help in finding (healthy?) patients at higher risk, it remains unclear whether interventions (medication, lifestyle) are more (cost-)effective in this high-risk subgroup. The role of troponin levels as a prognostic marker in stable patients therefore remains to be determined.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Imaging Studies for Cardiovascular System V: CT


